2550 Phase Ib study of abiraterone acetate (AA) plus buparlisib (BKM120) or BEZ235 in patients (pts) with castration-resistant prostate cancer (CRPC)
2018 ◽
Vol 14
(3)
◽
pp. 233-238
◽
2021 ◽
Vol 37
(4)
◽
pp. 635-642